$CLST

Price Over Earnings Overview: Catalyst Bancorp - Catalyst Bancorp (NASDAQ:CLST)

In the current market session, Catalyst Bancorp Inc. CLST stock price is at $12.00, after a 1.88% decrease. However, over the past month, the company's stock went up by 6.79%, and in the past year, by 8.69%.

Original reporting
Benzinga · Benzinga Insights
Published Jun 23, 2025, 5:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 23, 2025, 6:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Price Over Earnings Overview: Catalyst Bancorp - Catalyst Bancorp (NASDAQ:CLST) — source image
Decision brief

The 30-second read

$CLSTNeutralLow
01

Why it matters

The current news suggests limited immediate impact, but investors should monitor upcoming earnings and macroeconomic factors.

02

Market read

The news has limited immediate trading relevance but provides context for ongoing stability.

03

What to watch

Potential upcoming earnings reports or macroeconomic developments could alter the stock's trajectory, which are not covered in this brief.

Timing: short-term

Background

Catalyst Bancorp has shown modest growth over the past year, with current valuation metrics indicating stability.

Company-level read

Ticker impact

$CLSTNeutralMedium confidence
Context

The news provides a moderate update on Catalyst Bancorp's stock performance and valuation metrics.

Expected impact

Minimal short-term price movement expected; potential for slight rebound or stabilization.

Evidence & confidence

The stock's recent performance shows stability with minor fluctuations, and the news does not reveal significant catalysts or risks that would cause substantial price shifts.

Market effects

The banking sector may experience slight sentiment shifts due to the company's stable performance.

Limited regional impact given the company's size and market presence.

Negligible; the news does not affect global markets.

Counterpoint

Some investors might interpret the lack of significant positive catalysts as a sign to wait for clearer signals before trading.

Key entities

  • Catalyst Bancorp

    A regional banking institution listed on NASDAQ.

Related articles

$CLSTMed

Catalyst Bancorp, Inc. (CLST): Results of Operations and Financial Condition

Catalyst Bancorp, Inc. (CLST) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 For more information: Joe Zanco, President and CEO (337) 948-3033 ​ For Immediate Release Release Date: July 30, 2026 ​ Catalyst Bancorp, Inc. Announces 2026 Second Quarter Results Opelousas, Louisiana – Catalyst Bancorp, Inc. (Nasdaq: “CLST”) (the “Company”), the pa

$CLSTMed

Catalyst Bancorp, Inc. (CLST): Completion of Acquisition or Disposition of Assets

Catalyst Bancorp, Inc. (CLST) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Catalyst Bancorp, Inc._July 14, 2026 0001849867 false 0001849867 2026-07-14 2026-07-14 ​ ​ ​ UNITED STATES SECURITIES AND EXCHANGE COMMISSION ​ Washington, D.C. 20549 ​ FORM 8-K ​ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ​ ​ ​ Date of

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.